NASDAQ:NXLIW

Nexalin Technology (NXLIW) Stock Price, News & Analysis

$0.07
-0.04 (-35.81%)
(As of 05/17/2024 ET)
Today's Range
$0.07
$0.11
50-Day Range
$0.02
$0.45
52-Week Range
$0.01
$0.56
Volume
377 shs
Average Volume
35,898 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Nexalin Technology

Nexalin Technology, Inc., a medical device company, designs and develops neurostimulation products for the treatment of mental health in the United States and China. It licenses and markets Nexalin Device, a non-invasive and drug-free therapy for the treatment of anxiety and insomnia. The company's Nexalin device emits a patented frequency-based waveform, which stimulates a positive response from the mid-brain structures associated with various mental health disorders. In addition, it designs and develops Generation 2 and Generation 3, a medical device that is in clinical trials for the treatment of substance abuse issues related to opiate, cocaine, alcohol abuse, Alzheimer's disease, and dementia. The company is based in Houston, Texas.

NXLIW Stock Price History

NXLIW Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive NXLIW Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nexalin Technology and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
NASDAQ:NXLIW
Fax
N/A
Employees
6
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$158,859.00

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Ms. Marilyn Elson (Age 71)
    Controller
    Comp: $382.72k
  • Mr. Mark White (Age 62)
    President, CEO, CFO & Director
    Comp: $191.29k
  • Mr. John Patrick Claude
    Co-Founder and Director of Engineering & Development
  • Dr. David Owens M.D. (Age 63)
    Chief Medical Officer & Director
  • Mr. Michael Nketiah (Age 48)
    Senior Vice-President of Quality, Regulatory & Clinical Affairs
    Comp: $251.6k

NXLIW Stock Analysis - Frequently Asked Questions

How have NXLIW shares performed in 2024?

Nexalin Technology's stock was trading at $0.0088 at the start of the year. Since then, NXLIW stock has increased by 714.8% and is now trading at $0.0717.
View the best growth stocks for 2024 here
.

How do I buy shares of Nexalin Technology?

Shares of NXLIW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:NXLIW) was last updated on 5/19/2024 by MarketBeat.com Staff

From Our Partners